Home > Recommended

Goods high definition for Live Lyophilized Vaccination Finished Products of Varicella Vaccine Live export to Qatar Manufacturer

Share to:  
  • Product Detail
  • Product Tags
  • Buyer Reviews

and have the certification ISO/TS16949:2009. We are dedicated to supply you high quality products with reasonable price. for Finished Products of Varicella Vaccine,Stored and Transported,With Cold Chain in Dark. Buyers Foremost. "Waiting for your inquiry.

Goods high definition for Live Lyophilized Vaccination Finished Products of Varicella Vaccine Live export to Qatar Manufacturer



In a clinical trial involving 928 people of 13 years old and above immunized by the product, the total occurrence rate of systemic reactions was 28.76% which was mainly fever, please see table 3, and the total occurrence rate of local reactions was 8.24% which was mainly redness, swelling and pain, please see table 4.

Table 3   Systemic reactions in 13 years old and above

Dose

Age/ years

Group

Cases (n)

Mild (%)

Moderate (%)

Severe (%)

Total (%)

First dose

13~16

The product

299

69 (23.08)

14 (4.68)

0 (0.00)

83 (27.76)

Control

149

53 (35.57)

4 (2.68)

0 (0.00)

57 (38.26)

17~50

The product

320

49 (15.31)

3 (0.94)

1 (0.31)

53 (16.56)

Control

160

21 (13.13)

6 (3.75)

0 (0.00)

27 (16.88)

Total

The product

619

118 (19.06)

17 (2.75)

1 (0.16)

136 (21.97)

Control

309

74 (23.95)

10 (3.24)

0 (0.00)

84 (27.18)

Second dose

13~16

The product

293

41 (13.99)

4 (1.37)

1 (0.34)

46 (15.70)

Control

146

19 (13.01)

4 (2.74)

0 (0.00)

23 (15.75)

17~50

The product

307

21 (6.84)

0 (0.00)

0 (0.00)

21 (6.84)

Control

154

15 (9.74)

1 (0.65)

1 (0.65)

17 (11.04)

Total

The product

600

62 (10.33)

4 (0.67)

1 (0.17)

67 (11.17)

Control

300

34 (11.33)

5 (1.67)

1 (0.33)

40 (13.33)

Total

13~50

The product

619

155 (25.04)

21 (3.39)

2 (0.32)

178 (28.76)

Control

309

88 (28.48)

14 (4.53)

1 (0.32)

103 (33.33)

 

Table 4   Local reactions in 13 years old and above

Dose

Age/years

Group

Cases (n)

Mild (%)

Moderate (%)

Severe (%)

Total (%)

First dose

13~16

The product

299

10 (3.34)

5 (1.67)

1 (0.33)

16 (5.35)

Control

149

10 (6.71)

4 (2.68)

0 (0.00)

14 (9.40)

17~50

The product

320

21 (6.56)

8 (2.50)

2 (0.63)

31 (9.69)

Control

160

22 (13.75)

11 (6.88)

4 (2.50)

37 (23.13)

Total

The product

619

31 (5.01)

13 (2.10)

3 (0.48)

47 (7.59)

Control

309

32 (10.36)

15 (4.85)

4 (1.29)

51 (16.50)

Second dose

13~16

The product

293

4 (1.37)

1 (0.34)

0 (0.00)

5 (1.71)

Control

146

1 (0.68)

0 (0.00)

0 (0.00)

1 (0.68)

17~50

The product

307

1 (0.33)

1(0.33)

0 (0.00)

2 (0.65)

Control

154

1 (0.65)

0 (0.00)

0 (0.00)

1 (0.65)

Total

The product

600

5 (0.83)

2 (0.33)

0 (0.00)

7 (1.17)

Control

300

2 (0.67)

0 (0.00)

0 (0.00)

2 (0.67)

Total

13~50

The product

619

35 (5.65)

13 (2.10)

3 (0.48)

51 (8.24)

Control

309

32 (10.36)

15 (4.85)

4 (1.29)

51 (16.50)

There is no significant difference between vaccine group and control group in table 3 and 4.


Penicillin Bottle Varicella Vaccine

"We insist about the theory of growth of 'High excellent, Performance, Sincerity and Down-to-earth working approach' to offer you with great company of processing for Finished Products of Varicella Vaccine Live. The product will supply to all over the world, such as: Czech Republic,Switzerland,Chile. Due to the stability of our products and solutions timely supply and our sincere service we've been able to sell our solutions not only over the domestic market but also exported to countries and regions including the Middle East, Asia, Europe and other countries and regions. At the same time we also undertake OEM and ODM orders. We are going to do our best to serve your company and establish a successful and friendly cooperation with you.

Email To This Supplier

Your message must be between 20-8000 characters

YOU MAY LIKE

Communicate with Supplier?Supplier
Jason Jiang Mr. Jason Jiang
What can I do for you?
Contact Supplier